nimbolide has been researched along with Waldenstrom Macroglobulinemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ailawadhi, S; Akhtar, S; Blake, MK; Caulfield, TR; Chanan-Khan, A; Chitta, K; Heckman, MG; Knight, J; Paulus, A; Pinkerton, A | 1 |
1 other study(ies) available for nimbolide and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia.
Topics: Animals; Apoptosis; Cell Line, Tumor; Female; Humans; Jurkat Cells; Limonins; Male; Mice; Mice, SCID; Neoplasms, Experimental; Proto-Oncogene Proteins c-bcl-2; Waldenstrom Macroglobulinemia; Xenograft Model Antitumor Assays | 2014 |